Suppr超能文献

肾上腺皮质癌的根治性手术切除:基于条件无病概率确定长期预后

Curative Surgical Resection of Adrenocortical Carcinoma: Determining Long-term Outcome Based on Conditional Disease-free Probability.

作者信息

Kim Yuhree, Margonis Georgios A, Prescott Jason D, Tran Thuy B, Postlewait Lauren M, Maithel Shishir K, Wang Tracy S, Glenn Jason A, Hatzaras Ioannis, Shenoy Rivfka, Phay John E, Keplinger Kara, Fields Ryan C, Jin Linda X, Weber Sharon M, Salem Ahmed, Sicklick Jason K, Gad Shady, Yopp Adam C, Mansour John C, Duh Quan-Yang, Seiser Natalie, Solorzano Carmen C, Kiernan Colleen M, Votanopoulos Konstantinos I, Levine Edward A, Poultsides George A, Pawlik Timothy M

机构信息

Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD.

Department of Surgery, Stanford University School of Medicine, Stanford, CA.

出版信息

Ann Surg. 2017 Jan;265(1):197-204. doi: 10.1097/SLA.0000000000001527.

Abstract

OBJECTIVE

To evaluate conditional disease-free survival (CDFS) for patients who underwent curative intent surgery for adrenocortical carcinoma (ACC).

BACKGROUND

ACC is a rare but aggressive tumor. Survival estimates are usually reported as survival from the time of surgery. CDFS estimates may be more clinically relevant by accounting for the changing likelihood of disease-free survival (DFS) according to time elapsed after surgery.

METHODS

CDFS was assessed using a multi-institutional cohort of patients. Cox proportional hazards models were used to evaluate factors associated with DFS. Three-year CDFS (CDFS3) estimates at "x" year after surgery were calculated as follows: CDFS3 = DFS(x+3)/DFS(x).

RESULTS

One hundred ninety-two patients were included in the study cohort; median patient age was 52 years. On presentation, 36% of patients had a functional tumor and median size was 11.5 cm. Most patients underwent R0 resection (75%) and 9% had N1 disease. Overall 1-, 3-, and 5-year DFS was 59%, 34%, and 22%, respectively. Using CDFS estimates, the probability of remaining disease free for an additional 3 years given that the patient had survived without disease at 1, 3, and 5 years, was 43%, 53%, and 70%, respectively. Patients with less favorable prognosis at baseline demonstrated the greatest increase in CDFS3 over time (eg, capsular invasion: 28%-88%, Δ60% vs no capsular invasion: 51%-87%, Δ36%).

CONCLUSIONS

DFS estimates for patients with ACC improved dramatically over time, in particular among patients with initial worse prognoses. CDFS estimates may provide more clinically relevant information about the changing likelihood of DFS over time.

摘要

目的

评估接受肾上腺皮质癌(ACC)根治性手术患者的无病生存条件(CDFS)。

背景

ACC是一种罕见但侵袭性强的肿瘤。生存估计通常报告为自手术时起的生存情况。通过考虑术后经过时间无病生存(DFS)可能性的变化,CDFS估计可能在临床上更具相关性。

方法

使用多机构患者队列评估CDFS。采用Cox比例风险模型评估与DFS相关的因素。术后“x”年的三年CDFS(CDFS3)估计值计算如下:CDFS3 = DFS(x + 3)/DFS(x)。

结果

研究队列纳入192例患者;患者中位年龄为52岁。就诊时,36%的患者有功能性肿瘤,中位大小为11.5厘米。大多数患者接受了R0切除(75%),9%有N1期疾病。总体1年、3年和5年DFS分别为59%、34%和22%。使用CDFS估计值,患者在1年、3年和5年无病生存后再无病生存3年的概率分别为43%、53%和70%。基线预后较差的患者随着时间推移CDFS3增加最大(例如,包膜侵犯:28% - 88%,差值60%,无包膜侵犯:51% - 87%,差值36%)。

结论

ACC患者的DFS估计随时间显著改善,尤其是初始预后较差的患者。CDFS估计可能提供关于DFS随时间变化可能性的更具临床相关性的信息。

相似文献

2
Conditional disease-free survival after curative-intent liver resection for neuroendocrine liver metastasis.
J Surg Oncol. 2019 Dec;120(7):1087-1095. doi: 10.1002/jso.25713. Epub 2019 Sep 24.
5
Conditional disease-free survival after liver transplantation for hepatocellular carcinoma: A two-center experience.
Medicine (Baltimore). 2016 Aug;95(31):e4383. doi: 10.1097/MD.0000000000004383.
6
Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma.
J Am Coll Surg. 2016 Dec;223(6):794-803. doi: 10.1016/j.jamcollsurg.2016.08.568. Epub 2016 Sep 13.
7
Disparities in access to care and outcomes in patients with adrenocortical carcinoma.
J Surg Res. 2017 Jun 1;213:138-146. doi: 10.1016/j.jss.2017.02.046. Epub 2017 Mar 3.
8
Resection of adrenocortical carcinoma liver metastasis: is it justified?
Ann Surg Oncol. 2012 Aug;19(8):2643-51. doi: 10.1245/s10434-012-2358-7. Epub 2012 Apr 21.
10
Outcomes after resection of cortisol-secreting adrenocortical carcinoma.
Am J Surg. 2016 Jun;211(6):1106-13. doi: 10.1016/j.amjsurg.2015.09.020. Epub 2015 Dec 31.

引用本文的文献

5
Conditional Survival of female patients with operable invasive Breast Cancer in US: A population-based study.
J Cancer. 2020 Jul 31;11(19):5782-5791. doi: 10.7150/jca.46183. eCollection 2020.
6
Conditional disease-free survival in high-risk renal cell carcinoma treated with sunitinib.
Aging (Albany NY). 2019 Dec 11;11(23):11490-11503. doi: 10.18632/aging.102549.
7
Conditional survival and recurrence of remnant gastric cancer after surgical resection: A multi-institutional study.
Cancer Sci. 2020 Feb;111(2):502-512. doi: 10.1111/cas.14231. Epub 2019 Dec 26.
9
Conditional Survival in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab.
Med Sci Monit. 2019 Aug 30;25:6518-6522. doi: 10.12659/MSM.916984.
10
Conditional survival analysis of four treatment strategies for patients with stage I non-small cell lung cancer.
Oncol Lett. 2019 Aug;18(2):1089-1098. doi: 10.3892/ol.2019.10413. Epub 2019 May 30.

本文引用的文献

3
Conditional survival analysis of hepatocellular carcinoma patients treated with radiofrequency ablation.
Hepatol Res. 2015 Oct;45(10):E62-72. doi: 10.1111/hepr.12458. Epub 2015 Jan 8.
4
A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease.
Surgery. 2014 Dec;156(6):1378-85; discussion 1385-6. doi: 10.1016/j.surg.2014.08.018. Epub 2014 Nov 11.
5
Prognosis and conditional disease-free survival among patients with ovarian cancer.
J Clin Oncol. 2014 Dec 20;32(36):4102-12. doi: 10.1200/JCO.2014.55.1713. Epub 2014 Nov 17.
6
Conditional survival in patients with thyroid cancer.
Thyroid. 2014 Dec;24(12):1784-9. doi: 10.1089/thy.2014.0264.
7
Conditional survival after radical nephroureterectomy for upper tract carcinoma.
Eur Urol. 2015 Apr;67(4):803-12. doi: 10.1016/j.eururo.2014.08.003. Epub 2014 Aug 19.
8
Treatment patterns and outcomes for patients with adrenocortical carcinoma associated with hospital case volume in the United States.
Ann Surg Oncol. 2014 Oct;21(11):3509-14. doi: 10.1245/s10434-014-3931-z. Epub 2014 Jul 29.
9
Adrenocortical carcinoma: review and update.
Adv Anat Pathol. 2014 May;21(3):151-9. doi: 10.1097/PAP.0000000000000019.
10
Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time.
Eur Urol. 2014 Aug;66(2):361-70. doi: 10.1016/j.eururo.2013.09.050. Epub 2013 Oct 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验